NEFL and myeloid sarcoma: Notably, the BENEFIT‐11 study found that neurofilament light chain (NfL) levels, a biomarker of neuronal damage, were approximately 20% higher in MS patients who smoked, suggesting a potential link between smoking behavior and neurodegeneration (Yang et al.